반응식
Cl[C:2]1[CH:3]=[CH:4][C:5]2[N:6]([C:8]([CH:11]([F:13])[F:12])=[N:9][N:10]=2)[N:7]=1.[N:14]1([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:19][CH2:18][NH:17][CH2:16][CH2:15]1.CCN(C(C)C)C(C)C>CN(C=O)C>[F:12][CH:11]([F:13])[C:8]1[N:6]2[N:7]=[C:2]([N:17]3[CH2:16][CH2:15][N:14]([C:20]([O:22][C:23]([CH3:26])([CH3:25])[CH3:24])=[O:21])[CH2:19][CH2:18]3)[CH:3]=[CH:4][C:5]2=[N:10][N:9]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
실험 절차
A stirred solution of 6-chloro-3-(difluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazine (3.07 g, 15 mmol), tert-butyl piperazine-1-carboxylate (3.35 g, 18.00 mmol) and DIPEA (3.85 mL, 22.50 mmol) in DMF (25 mL) was heated at 100° C. for 1 hour. The reaction mixture was evaporated to dryness, redissolved in DCM and washed sequentially with 1M aqueous K2CO3, water and saturated brine. The organic layer was dried over MgSO4, filtered and evaporated. The crude product was triturated with ether and the solid was collected by filtration, washed with ether and dried under vacuum to afford tert-butyl 4-[3-(difluoromethyl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperazine-1-carboxylate (5.05 g, 95%) as a white crystalline solid.
후처리
- customThe reaction mixture was evaporated to dryness
- dissolutionredissolved in DCM
- washwashed sequentially with 1M aqueous K2CO3, water and saturated brine
- dry with materialThe organic layer was dried over MgSO4
- filtrationfiltered
- customevaporated
- customThe crude product was triturated with ether
- filtrationthe solid was collected by filtration
- washwashed with ether
- customdried under vacuum
출처 및 근거
- ORD 기록
- ord-67098c7b72c3468c8892d0746c4f88dc
- 출처 데이터셋
- uspto-grants-2011_08
- 특허 번호
- US08003649B2
연결된 노트
불러오는 중…